カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の抗インフルエンザウイルス漢方薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Anti Influenza Virus Chinese Medicine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19136）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19136
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：122
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の抗インフルエンザウイルス漢方薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

抗インフルエンザウイルス漢方薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の抗インフルエンザウイルス漢方薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

抗インフルエンザウイルス漢方薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・内服液、カプセル、ロゼンジ、チュアブル錠、エアゾール、注射剤、丸剤、顆粒、シロップ

用途別セグメントは次のように区分されます。
・大人、子供

世界の抗インフルエンザウイルス漢方薬市場の主要な市場プレーヤーは以下のとおりです。
・Guangzhou Pharmaceutical、CR SANJIU、TASLY、China TCM、Yunnan Baiyao、Tongrentang、Jumpcan、Zhejiang Conba Pharmaceutical、Green Valley Pharma、Changbaishan Pharmaceutical、Zhejiang Kanglaite Pharmaceutical、Qingfeng Pharmaceutical Group、Buchang Pharmaceutical、Livzon、ZBD Pharmaceutical、Chase Sun Pharmaceutical、Wuzhou Pharmaceutical、Yusheng Pharmaceutical、Harbin Pharmaceutical Group、Fusen Pharmaceutical、Gerun Pharmaceutical、Shineway Pharmaceutical、Yiling Pharmaceutical、Harbin Pharmaceutical Group

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、抗インフルエンザウイルス漢方薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な抗インフルエンザウイルス漢方薬メーカーの企業概要、2019年～2022年までの抗インフルエンザウイルス漢方薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な抗インフルエンザウイルス漢方薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別抗インフルエンザウイルス漢方薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの抗インフルエンザウイルス漢方薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での抗インフルエンザウイルス漢方薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および抗インフルエンザウイルス漢方薬の産業チェーンを掲載しています。
・第13、14、15章では、抗インフルエンザウイルス漢方薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 抗インフルエンザウイルス漢方薬の概要
- 種類別分析（2017年vs2021年vs2028年）：内服液、カプセル、ロゼンジ、チュアブル錠、エアゾール、注射剤、丸剤、顆粒、シロップ
- 用途別分析（2017年vs2021年vs2028年）：大人、子供
- 世界の抗インフルエンザウイルス漢方薬市場規模・予測
- 世界の抗インフルエンザウイルス漢方薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Guangzhou Pharmaceutical、CR SANJIU、TASLY、China TCM、Yunnan Baiyao、Tongrentang、Jumpcan、Zhejiang Conba Pharmaceutical、Green Valley Pharma、Changbaishan Pharmaceutical、Zhejiang Kanglaite Pharmaceutical、Qingfeng Pharmaceutical Group、Buchang Pharmaceutical、Livzon、ZBD Pharmaceutical、Chase Sun Pharmaceutical、Wuzhou Pharmaceutical、Yusheng Pharmaceutical、Harbin Pharmaceutical Group、Fusen Pharmaceutical、Gerun Pharmaceutical、Shineway Pharmaceutical、Yiling Pharmaceutical、Harbin Pharmaceutical Group
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：内服液、カプセル、ロゼンジ、チュアブル錠、エアゾール、注射剤、丸剤、顆粒、シロップ
・用途別分析2017年-2028年：大人、子供
・抗インフルエンザウイルス漢方薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・抗インフルエンザウイルス漢方薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・抗インフルエンザウイルス漢方薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・抗インフルエンザウイルス漢方薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・抗インフルエンザウイルス漢方薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Anti Influenza Virus Chinese Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Anti Influenza Virus Chinese Medicine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adult accounting for % of the Anti Influenza Virus Chinese Medicine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral Solution segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anti Influenza Virus Chinese Medicine include Guangzhou Pharmaceutical, CR SANJIU, TASLY, China TCM, and Yunnan Baiyao, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anti Influenza Virus Chinese Medicine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral Solution
Capsule
Lozenges
Chewable Tablets
Aerosol
Injection
Pills
Particles
Syrup
Market segment by Application can be divided into
Adult
Children
The key market players for global Anti Influenza Virus Chinese Medicine market are listed below:
Guangzhou Pharmaceutical
CR SANJIU
TASLY
China TCM
Yunnan Baiyao
Tongrentang
Jumpcan
Zhejiang Conba Pharmaceutical
Green Valley Pharma
Changbaishan Pharmaceutical
Zhejiang Kanglaite Pharmaceutical
Qingfeng Pharmaceutical Group
Buchang Pharmaceutical
Livzon
ZBD Pharmaceutical
Chase Sun Pharmaceutical
Wuzhou Pharmaceutical
Yusheng Pharmaceutical
Harbin Pharmaceutical Group
Fusen Pharmaceutical
Gerun Pharmaceutical
Shineway Pharmaceutical
Yiling Pharmaceutical
Harbin Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti Influenza Virus Chinese Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti Influenza Virus Chinese Medicine, with price, sales, revenue and global market share of Anti Influenza Virus Chinese Medicine from 2019 to 2022.
Chapter 3, the Anti Influenza Virus Chinese Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti Influenza Virus Chinese Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anti Influenza Virus Chinese Medicine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti Influenza Virus Chinese Medicine.
Chapter 13, 14, and 15, to describe Anti Influenza Virus Chinese Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Anti Influenza Virus Chinese Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti Influenza Virus Chinese Medicine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oral Solution
1.2.3 Capsule
1.2.4 Lozenges
1.2.5 Chewable Tablets
1.2.6 Aerosol
1.2.7 Injection
1.2.8 Pills
1.2.9 Particles
1.2.10 Syrup
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti Influenza Virus Chinese Medicine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adult
1.3.3 Children
1.4 Global Anti Influenza Virus Chinese Medicine Market Size & Forecast
1.4.1 Global Anti Influenza Virus Chinese Medicine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anti Influenza Virus Chinese Medicine Sales in Volume (2017-2028)
1.4.3 Global Anti Influenza Virus Chinese Medicine Price (2017-2028)
1.5 Global Anti Influenza Virus Chinese Medicine Production Capacity Analysis
1.5.1 Global Anti Influenza Virus Chinese Medicine Total Production Capacity (2017-2028)
1.5.2 Global Anti Influenza Virus Chinese Medicine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti Influenza Virus Chinese Medicine Market Drivers
1.6.2 Anti Influenza Virus Chinese Medicine Market Restraints
1.6.3 Anti Influenza Virus Chinese Medicine Trends Analysis
2 Manufacturers Profiles
2.1 Guangzhou Pharmaceutical
2.1.1 Guangzhou Pharmaceutical Details
2.1.2 Guangzhou Pharmaceutical Major Business
2.1.3 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
2.1.4 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CR SANJIU
2.2.1 CR SANJIU Details
2.2.2 CR SANJIU Major Business
2.2.3 CR SANJIU Anti Influenza Virus Chinese Medicine Product and Services
2.2.4 CR SANJIU Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 TASLY
2.3.1 TASLY Details
2.3.2 TASLY Major Business
2.3.3 TASLY Anti Influenza Virus Chinese Medicine Product and Services
2.3.4 TASLY Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 China TCM
2.4.1 China TCM Details
2.4.2 China TCM Major Business
2.4.3 China TCM Anti Influenza Virus Chinese Medicine Product and Services
2.4.4 China TCM Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Yunnan Baiyao
2.5.1 Yunnan Baiyao Details
2.5.2 Yunnan Baiyao Major Business
2.5.3 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product and Services
2.5.4 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Tongrentang
2.6.1 Tongrentang Details
2.6.2 Tongrentang Major Business
2.6.3 Tongrentang Anti Influenza Virus Chinese Medicine Product and Services
2.6.4 Tongrentang Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Jumpcan
2.7.1 Jumpcan Details
2.7.2 Jumpcan Major Business
2.7.3 Jumpcan Anti Influenza Virus Chinese Medicine Product and Services
2.7.4 Jumpcan Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Zhejiang Conba Pharmaceutical
2.8.1 Zhejiang Conba Pharmaceutical Details
2.8.2 Zhejiang Conba Pharmaceutical Major Business
2.8.3 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
2.8.4 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Green Valley Pharma
2.9.1 Green Valley Pharma Details
2.9.2 Green Valley Pharma Major Business
2.9.3 Green Valley Pharma Anti Influenza Virus Chinese Medicine Product and Services
2.9.4 Green Valley Pharma Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Changbaishan Pharmaceutical
2.10.1 Changbaishan Pharmaceutical Details
2.10.2 Changbaishan Pharmaceutical Major Business
2.10.3 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
2.10.4 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Zhejiang Kanglaite Pharmaceutical
2.11.1 Zhejiang Kanglaite Pharmaceutical Details
2.11.2 Zhejiang Kanglaite Pharmaceutical Major Business
2.11.3 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
2.11.4 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Qingfeng Pharmaceutical Group
2.12.1 Qingfeng Pharmaceutical Group Details
2.12.2 Qingfeng Pharmaceutical Group Major Business
2.12.3 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product and Services
2.12.4 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Buchang Pharmaceutical
2.13.1 Buchang Pharmaceutical Details
2.13.2 Buchang Pharmaceutical Major Business
2.13.3 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
2.13.4 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Livzon
2.14.1 Livzon Details
2.14.2 Livzon Major Business
2.14.3 Livzon Anti Influenza Virus Chinese Medicine Product and Services
2.14.4 Livzon Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 ZBD Pharmaceutical
2.15.1 ZBD Pharmaceutical Details
2.15.2 ZBD Pharmaceutical Major Business
2.15.3 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
2.15.4 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Chase Sun Pharmaceutical
2.16.1 Chase Sun Pharmaceutical Details
2.16.2 Chase Sun Pharmaceutical Major Business
2.16.3 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
2.16.4 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Wuzhou Pharmaceutical
2.17.1 Wuzhou Pharmaceutical Details
2.17.2 Wuzhou Pharmaceutical Major Business
2.17.3 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
2.17.4 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Yusheng Pharmaceutical
2.18.1 Yusheng Pharmaceutical Details
2.18.2 Yusheng Pharmaceutical Major Business
2.18.3 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
2.18.4 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Harbin Pharmaceutical Group
2.19.1 Harbin Pharmaceutical Group Details
2.19.2 Harbin Pharmaceutical Group Major Business
2.19.3 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product and Services
2.19.4 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Fusen Pharmaceutical
2.20.1 Fusen Pharmaceutical Details
2.20.2 Fusen Pharmaceutical Major Business
2.20.3 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
2.20.4 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Gerun Pharmaceutical
2.21.1 Gerun Pharmaceutical Details
2.21.2 Gerun Pharmaceutical Major Business
2.21.3 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
2.21.4 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Shineway Pharmaceutical
2.22.1 Shineway Pharmaceutical Details
2.22.2 Shineway Pharmaceutical Major Business
2.22.3 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
2.22.4 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Yiling Pharmaceutical
2.23.1 Yiling Pharmaceutical Details
2.23.2 Yiling Pharmaceutical Major Business
2.23.3 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
2.23.4 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24 Harbin Pharmaceutical Group
2.24.1 Harbin Pharmaceutical Group Details
2.24.2 Harbin Pharmaceutical Group Major Business
2.24.3 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product and Services
2.24.4 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anti Influenza Virus Chinese Medicine Breakdown Data by Manufacturer
3.1 Global Anti Influenza Virus Chinese Medicine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anti Influenza Virus Chinese Medicine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anti Influenza Virus Chinese Medicine
3.4 Market Concentration Rate
3.4.1 Top 3 Anti Influenza Virus Chinese Medicine Manufacturer Market Share in 2021
3.4.2 Top 6 Anti Influenza Virus Chinese Medicine Manufacturer Market Share in 2021
3.5 Global Anti Influenza Virus Chinese Medicine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anti Influenza Virus Chinese Medicine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti Influenza Virus Chinese Medicine Market Size by Region
4.1.1 Global Anti Influenza Virus Chinese Medicine Sales in Volume by Region (2017-2028)
4.1.2 Global Anti Influenza Virus Chinese Medicine Revenue by Region (2017-2028)
4.2 North America Anti Influenza Virus Chinese Medicine Revenue (2017-2028)
4.3 Europe Anti Influenza Virus Chinese Medicine Revenue (2017-2028)
4.4 Asia-Pacific Anti Influenza Virus Chinese Medicine Revenue (2017-2028)
4.5 South America Anti Influenza Virus Chinese Medicine Revenue (2017-2028)
4.6 Middle East and Africa Anti Influenza Virus Chinese Medicine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anti Influenza Virus Chinese Medicine Sales in Volume by Type (2017-2028)
5.2 Global Anti Influenza Virus Chinese Medicine Revenue by Type (2017-2028)
5.3 Global Anti Influenza Virus Chinese Medicine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anti Influenza Virus Chinese Medicine Sales in Volume by Application (2017-2028)
6.2 Global Anti Influenza Virus Chinese Medicine Revenue by Application (2017-2028)
6.3 Global Anti Influenza Virus Chinese Medicine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anti Influenza Virus Chinese Medicine Sales by Type (2017-2028)
7.2 North America Anti Influenza Virus Chinese Medicine Sales by Application (2017-2028)
7.3 North America Anti Influenza Virus Chinese Medicine Market Size by Country
7.3.1 North America Anti Influenza Virus Chinese Medicine Sales in Volume by Country (2017-2028)
7.3.2 North America Anti Influenza Virus Chinese Medicine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti Influenza Virus Chinese Medicine Sales by Type (2017-2028)
8.2 Europe Anti Influenza Virus Chinese Medicine Sales by Application (2017-2028)
8.3 Europe Anti Influenza Virus Chinese Medicine Market Size by Country
8.3.1 Europe Anti Influenza Virus Chinese Medicine Sales in Volume by Country (2017-2028)
8.3.2 Europe Anti Influenza Virus Chinese Medicine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Type (2017-2028)
9.2 Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Application (2017-2028)
9.3 Asia-Pacific Anti Influenza Virus Chinese Medicine Market Size by Region
9.3.1 Asia-Pacific Anti Influenza Virus Chinese Medicine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anti Influenza Virus Chinese Medicine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anti Influenza Virus Chinese Medicine Sales by Type (2017-2028)
10.2 South America Anti Influenza Virus Chinese Medicine Sales by Application (2017-2028)
10.3 South America Anti Influenza Virus Chinese Medicine Market Size by Country
10.3.1 South America Anti Influenza Virus Chinese Medicine Sales in Volume by Country (2017-2028)
10.3.2 South America Anti Influenza Virus Chinese Medicine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Type (2017-2028)
11.2 Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Application (2017-2028)
11.3 Middle East & Africa Anti Influenza Virus Chinese Medicine Market Size by Country
11.3.1 Middle East & Africa Anti Influenza Virus Chinese Medicine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anti Influenza Virus Chinese Medicine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anti Influenza Virus Chinese Medicine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anti Influenza Virus Chinese Medicine
12.3 Anti Influenza Virus Chinese Medicine Production Process
12.4 Anti Influenza Virus Chinese Medicine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anti Influenza Virus Chinese Medicine Typical Distributors
13.3 Anti Influenza Virus Chinese Medicine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Anti Influenza Virus Chinese Medicine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Anti Influenza Virus Chinese Medicine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Guangzhou Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Guangzhou Pharmaceutical Major Business
Table 5. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
Table 6. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. CR SANJIU Basic Information, Manufacturing Base and Competitors
Table 8. CR SANJIU Major Business
Table 9. CR SANJIU Anti Influenza Virus Chinese Medicine Product and Services
Table 10. CR SANJIU Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. TASLY Basic Information, Manufacturing Base and Competitors
Table 12. TASLY Major Business
Table 13. TASLY Anti Influenza Virus Chinese Medicine Product and Services
Table 14. TASLY Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. China TCM Basic Information, Manufacturing Base and Competitors
Table 16. China TCM Major Business
Table 17. China TCM Anti Influenza Virus Chinese Medicine Product and Services
Table 18. China TCM Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Yunnan Baiyao Basic Information, Manufacturing Base and Competitors
Table 20. Yunnan Baiyao Major Business
Table 21. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product and Services
Table 22. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Tongrentang Basic Information, Manufacturing Base and Competitors
Table 24. Tongrentang Major Business
Table 25. Tongrentang Anti Influenza Virus Chinese Medicine Product and Services
Table 26. Tongrentang Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Jumpcan Basic Information, Manufacturing Base and Competitors
Table 28. Jumpcan Major Business
Table 29. Jumpcan Anti Influenza Virus Chinese Medicine Product and Services
Table 30. Jumpcan Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Zhejiang Conba Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Zhejiang Conba Pharmaceutical Major Business
Table 33. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
Table 34. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Green Valley Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Green Valley Pharma Major Business
Table 37. Green Valley Pharma Anti Influenza Virus Chinese Medicine Product and Services
Table 38. Green Valley Pharma Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Changbaishan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Changbaishan Pharmaceutical Major Business
Table 41. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
Table 42. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Zhejiang Kanglaite Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Zhejiang Kanglaite Pharmaceutical Major Business
Table 45. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
Table 46. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Qingfeng Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 48. Qingfeng Pharmaceutical Group Major Business
Table 49. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product and Services
Table 50. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Buchang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Buchang Pharmaceutical Major Business
Table 53. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
Table 54. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Livzon Basic Information, Manufacturing Base and Competitors
Table 56. Livzon Major Business
Table 57. Livzon Anti Influenza Virus Chinese Medicine Product and Services
Table 58. Livzon Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. ZBD Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. ZBD Pharmaceutical Major Business
Table 61. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
Table 62. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Chase Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Chase Sun Pharmaceutical Major Business
Table 65. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
Table 66. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Wuzhou Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Wuzhou Pharmaceutical Major Business
Table 69. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
Table 70. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Yusheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 72. Yusheng Pharmaceutical Major Business
Table 73. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
Table 74. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 76. Harbin Pharmaceutical Group Major Business
Table 77. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product and Services
Table 78. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Fusen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Fusen Pharmaceutical Major Business
Table 81. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
Table 82. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Gerun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 84. Gerun Pharmaceutical Major Business
Table 85. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
Table 86. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Shineway Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 88. Shineway Pharmaceutical Major Business
Table 89. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
Table 90. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Yiling Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Yiling Pharmaceutical Major Business
Table 93. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services
Table 94. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 96. Harbin Pharmaceutical Group Major Business
Table 97. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product and Services
Table 98. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 99. Global Anti Influenza Virus Chinese Medicine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 100. Global Anti Influenza Virus Chinese Medicine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 101. Market Position of Manufacturers in Anti Influenza Virus Chinese Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 102. Global Anti Influenza Virus Chinese Medicine Production Capacity by Company, (K Units): 2020 VS 2021
Table 103. Head Office and Anti Influenza Virus Chinese Medicine Production Site of Key Manufacturer
Table 104. Anti Influenza Virus Chinese Medicine New Entrant and Capacity Expansion Plans
Table 105. Anti Influenza Virus Chinese Medicine Mergers & Acquisitions in the Past Five Years
Table 106. Global Anti Influenza Virus Chinese Medicine Sales by Region (2017-2022) & (K Units)
Table 107. Global Anti Influenza Virus Chinese Medicine Sales by Region (2023-2028) & (K Units)
Table 108. Global Anti Influenza Virus Chinese Medicine Revenue by Region (2017-2022) & (USD Million)
Table 109. Global Anti Influenza Virus Chinese Medicine Revenue by Region (2023-2028) & (USD Million)
Table 110. Global Anti Influenza Virus Chinese Medicine Sales by Type (2017-2022) & (K Units)
Table 111. Global Anti Influenza Virus Chinese Medicine Sales by Type (2023-2028) & (K Units)
Table 112. Global Anti Influenza Virus Chinese Medicine Revenue by Type (2017-2022) & (USD Million)
Table 113. Global Anti Influenza Virus Chinese Medicine Revenue by Type (2023-2028) & (USD Million)
Table 114. Global Anti Influenza Virus Chinese Medicine Price by Type (2017-2022) & (US$/Unit)
Table 115. Global Anti Influenza Virus Chinese Medicine Price by Type (2023-2028) & (US$/Unit)
Table 116. Global Anti Influenza Virus Chinese Medicine Sales by Application (2017-2022) & (K Units)
Table 117. Global Anti Influenza Virus Chinese Medicine Sales by Application (2023-2028) & (K Units)
Table 118. Global Anti Influenza Virus Chinese Medicine Revenue by Application (2017-2022) & (USD Million)
Table 119. Global Anti Influenza Virus Chinese Medicine Revenue by Application (2023-2028) & (USD Million)
Table 120. Global Anti Influenza Virus Chinese Medicine Price by Application (2017-2022) & (US$/Unit)
Table 121. Global Anti Influenza Virus Chinese Medicine Price by Application (2023-2028) & (US$/Unit)
Table 122. North America Anti Influenza Virus Chinese Medicine Sales by Country (2017-2022) & (K Units)
Table 123. North America Anti Influenza Virus Chinese Medicine Sales by Country (2023-2028) & (K Units)
Table 124. North America Anti Influenza Virus Chinese Medicine Revenue by Country (2017-2022) & (USD Million)
Table 125. North America Anti Influenza Virus Chinese Medicine Revenue by Country (2023-2028) & (USD Million)
Table 126. North America Anti Influenza Virus Chinese Medicine Sales by Type (2017-2022) & (K Units)
Table 127. North America Anti Influenza Virus Chinese Medicine Sales by Type (2023-2028) & (K Units)
Table 128. North America Anti Influenza Virus Chinese Medicine Sales by Application (2017-2022) & (K Units)
Table 129. North America Anti Influenza Virus Chinese Medicine Sales by Application (2023-2028) & (K Units)
Table 130. Europe Anti Influenza Virus Chinese Medicine Sales by Country (2017-2022) & (K Units)
Table 131. Europe Anti Influenza Virus Chinese Medicine Sales by Country (2023-2028) & (K Units)
Table 132. Europe Anti Influenza Virus Chinese Medicine Revenue by Country (2017-2022) & (USD Million)
Table 133. Europe Anti Influenza Virus Chinese Medicine Revenue by Country (2023-2028) & (USD Million)
Table 134. Europe Anti Influenza Virus Chinese Medicine Sales by Type (2017-2022) & (K Units)
Table 135. Europe Anti Influenza Virus Chinese Medicine Sales by Type (2023-2028) & (K Units)
Table 136. Europe Anti Influenza Virus Chinese Medicine Sales by Application (2017-2022) & (K Units)
Table 137. Europe Anti Influenza Virus Chinese Medicine Sales by Application (2023-2028) & (K Units)
Table 138. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Region (2017-2022) & (K Units)
Table 139. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Region (2023-2028) & (K Units)
Table 140. Asia-Pacific Anti Influenza Virus Chinese Medicine Revenue by Region (2017-2022) & (USD Million)
Table 141. Asia-Pacific Anti Influenza Virus Chinese Medicine Revenue by Region (2023-2028) & (USD Million)
Table 142. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Type (2017-2022) & (K Units)
Table 143. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Type (2023-2028) & (K Units)
Table 144. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Application (2017-2022) & (K Units)
Table 145. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Application (2023-2028) & (K Units)
Table 146. South America Anti Influenza Virus Chinese Medicine Sales by Country (2017-2022) & (K Units)
Table 147. South America Anti Influenza Virus Chinese Medicine Sales by Country (2023-2028) & (K Units)
Table 148. South America Anti Influenza Virus Chinese Medicine Revenue by Country (2017-2022) & (USD Million)
Table 149. South America Anti Influenza Virus Chinese Medicine Revenue by Country (2023-2028) & (USD Million)
Table 150. South America Anti Influenza Virus Chinese Medicine Sales by Type (2017-2022) & (K Units)
Table 151. South America Anti Influenza Virus Chinese Medicine Sales by Type (2023-2028) & (K Units)
Table 152. South America Anti Influenza Virus Chinese Medicine Sales by Application (2017-2022) & (K Units)
Table 153. South America Anti Influenza Virus Chinese Medicine Sales by Application (2023-2028) & (K Units)
Table 154. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Region (2017-2022) & (K Units)
Table 155. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Region (2023-2028) & (K Units)
Table 156. Middle East & Africa Anti Influenza Virus Chinese Medicine Revenue by Region (2017-2022) & (USD Million)
Table 157. Middle East & Africa Anti Influenza Virus Chinese Medicine Revenue by Region (2023-2028) & (USD Million)
Table 158. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Type (2017-2022) & (K Units)
Table 159. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Type (2023-2028) & (K Units)
Table 160. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Application (2017-2022) & (K Units)
Table 161. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Application (2023-2028) & (K Units)
Table 162. Anti Influenza Virus Chinese Medicine Raw Material
Table 163. Key Manufacturers of Anti Influenza Virus Chinese Medicine Raw Materials
Table 164. Direct Channel Pros & Cons
Table 165. Indirect Channel Pros & Cons
Table 166. Anti Influenza Virus Chinese Medicine Typical Distributors
Table 167. Anti Influenza Virus Chinese Medicine Typical Customers
List of Figures
Figure 1. Anti Influenza Virus Chinese Medicine Picture
Figure 2. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type in 2021
Figure 3. Oral Solution
Figure 4. Capsule
Figure 5. Lozenges
Figure 6. Chewable Tablets
Figure 7. Aerosol
Figure 8. Injection
Figure 9. Pills
Figure 10. Particles
Figure 11. Syrup
Figure 12. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application in 2021
Figure 13. Adult
Figure 14. Children
Figure 15. Global Anti Influenza Virus Chinese Medicine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 16. Global Anti Influenza Virus Chinese Medicine Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Anti Influenza Virus Chinese Medicine Sales (2017-2028) & (K Units)
Figure 18. Global Anti Influenza Virus Chinese Medicine Price (2017-2028) & (US$/Unit)
Figure 19. Global Anti Influenza Virus Chinese Medicine Production Capacity (2017-2028) & (K Units)
Figure 20. Global Anti Influenza Virus Chinese Medicine Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Anti Influenza Virus Chinese Medicine Market Drivers
Figure 22. Anti Influenza Virus Chinese Medicine Market Restraints
Figure 23. Anti Influenza Virus Chinese Medicine Market Trends
Figure 24. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Manufacturer in 2021
Figure 25. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Manufacturer in 2021
Figure 26. Anti Influenza Virus Chinese Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Anti Influenza Virus Chinese Medicine Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Anti Influenza Virus Chinese Medicine Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2017-2028)
Figure 30. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Region (2017-2028)
Figure 31. North America Anti Influenza Virus Chinese Medicine Revenue (2017-2028) & (USD Million)
Figure 32. Europe Anti Influenza Virus Chinese Medicine Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Anti Influenza Virus Chinese Medicine Revenue (2017-2028) & (USD Million)
Figure 34. South America Anti Influenza Virus Chinese Medicine Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Anti Influenza Virus Chinese Medicine Revenue (2017-2028) & (USD Million)
Figure 36. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2017-2028)
Figure 37. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type (2017-2028)
Figure 38. Global Anti Influenza Virus Chinese Medicine Price by Type (2017-2028) & (US$/Unit)
Figure 39. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2017-2028)
Figure 40. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application (2017-2028)
Figure 41. Global Anti Influenza Virus Chinese Medicine Price by Application (2017-2028) & (US$/Unit)
Figure 42. North America Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2017-2028)
Figure 43. North America Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2017-2028)
Figure 44. North America Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2017-2028)
Figure 45. North America Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2017-2028)
Figure 46. United States Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2017-2028)
Figure 50. Europe Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2017-2028)
Figure 51. Europe Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2017-2028)
Figure 52. Europe Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2017-2028)
Figure 53. Germany Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Anti Influenza Virus Chinese Medicine Revenue Market Share by Region (2017-2028)
Figure 62. China Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2017-2028)
Figure 69. South America Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2017-2028)
Figure 70. South America Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2017-2028)
Figure 71. South America Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Anti Influenza Virus Chinese Medicine Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Anti Influenza Virus Chinese Medicine in 2021
Figure 83. Manufacturing Process Analysis of Anti Influenza Virus Chinese Medicine
Figure 84. Anti Influenza Virus Chinese Medicine Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の漢方注射市場2022年：市場規模予測（～2028年）
  • インフルエンザAウイルス抗原検出キットのグローバル市場展望 2023年-2029年：サンプルサイズ20人、サンプルサイズ40人
  • 漢方薬飲片加工のグローバル市場展望 2023年-2029年：根茎、全草、果実種子、その他
  • 漢方薬煎じ包装機のグローバル市場展望 2023年-2029年：卓上式、床置き式
  • 漢方医薬品超微粉砕機の世界市場2023年：振動、ターボ、エアフロー、高圧研削
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19136 )"世界の抗インフルエンザウイルス漢方薬市場2022年：市場規模予測（～2028年）" (英文：Global Anti Influenza Virus Chinese Medicine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。